"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Anavex Life Sciences Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Anavex Life Sciences Corp
Edited Transcript of AVXL earnings conference call or presentation 7-Aug-19 8:30pm GMT
- Oct 11th, 2019 6:04 am
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease
- Oct 9th, 2019 11:00 am
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’s Disease
- Oct 2nd, 2019 11:00 am
The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
- Sep 27th, 2019 11:56 am
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study
- Sep 27th, 2019 7:00 am
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
- Sep 26th, 2019 11:00 am
Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company
- Sep 25th, 2019 9:32 pm
Do Institutions Own Shares In Anavex Life Sciences Corp. (NASDAQ:AVXL)?
- Sep 19th, 2019 12:58 pm
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
- Sep 18th, 2019 11:00 am
What Makes Anavex Life Sciences (AVXL) a New Strong Buy Stock
- Sep 16th, 2019 1:00 pm
Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett Syndrome
- Sep 16th, 2019 11:00 am
Anavex Life Sciences to Present at the Janney Healthcare Conference 2019
- Sep 5th, 2019 11:00 am
Anavex Life Sciences Announces Initiation of the EXCELLENCE ANAVEX®2-73-RS-003 Clinical Study in Pediatric Patients with Rett Syndrome
- Sep 4th, 2019 11:00 am
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates
- Aug 7th, 2019 11:00 am
What's in the Cards for Perrigo (PRGO) This Earnings Season?
- Aug 6th, 2019 1:54 pm
Can Pharmacy Services Drive CVS Health's (CVS) Q2 Earnings?
- Aug 5th, 2019 3:21 pm
Can All-Line Growth Aid CVS Health's (CVS) Earnings in Q2?
- Aug 2nd, 2019 3:46 pm
What's in Store for Cardinal Health (CAH) in Q4 Earnings?
- Aug 2nd, 2019 1:26 pm
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019
- Aug 2nd, 2019 11:00 am
Henry Schein (HSIC) to Post Q2 Earnings: A Beat in Store?
- Aug 1st, 2019 3:55 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2019 VentureLine
Website developed by Digital Solutions